Followers | 31 |
Posts | 3875 |
Boards Moderated | 1 |
Alias Born | 09/24/2012 |
Friday, February 12, 2016 5:04:10 PM
I followed your post and decided to post the info here for all to see below.
Glta Stockholders!!!
Note That company's website shows up to date (website)copyright 2016...
******************************************************************
Anti-Human Phosphatidylserine Therapeutic Antibody (Bavituximab) from Creative Biolabs
Recombinant monoclonal antibody to phosphatidylserine. Bavituximab is a chimeric monoclonal antibody designed for the treatment of cancers and viral infections
Product Details
ItemAnti-Human Phosphatidylserine Therapeutic Antibody (Bavituximab)
Company Info
CompanyCreative Biolabs
Price Supplier PageView Company Product Page
Catalog NumberTAB-175
Quantity1mg
ApplicationsFuncS, IF, Neut, ELISA, FC, IP, ICC
Conjugate/Tag/LabelUnconjugated
ReactivityHuman
Antigenphosphatidylserine
HostMouse
Source/Expression SystemCHO
TemperatureStore the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples
Bavituximab (TAB-175)
Share:
Recombinant monoclonal antibody to phosphatidylserine. Bavituximab is a chimeric monoclonal antibody designed for the treatment of cancers and viral infections.
Datasheet
Specifications
ImmunogenLiposomes containing 70% phosphatidylserine and 30% phosphatidylglycerol.
Host AnimalMouse
DerivationChimeric (mouse/human)
TypeIgG1 - kappa
SpecificityTested positive against native human antigen.
Species ReactivityHuman
ApplicationsSuitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
CAS NO.648904-28-3
Generic NameBavituximab
Biological Half-Life30 hrs
UNIIQ16CT95N25
M.W.145.3 kDa
Related DiseaseInfluenza
Target
Alternative NamesBavituximab;648904-28-3;ch3G4;PGN401;Phosphatidylserine;PS;Ptd-L-Ser
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
See other products for "phosphatidylserine"
Recombinant Anti-Human phosphatidylserine VHH Single Domain Antibody ( NAB-1906-VHH )
>> MORE
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
45-1 Ramsey Road, Shirley, NY 11967, USA Tel: 1-631-871-5806 Fax: 1-631-207-8356 Email: info@creative-biolabs.com
Terms of Service-Privacy Policy © 2007 - 2016 Creative-Biolabs All Rights Reserved
Recent CDMO News
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM